Significance of cancer testis?associated antigens (SPAG9 and FBXO39) in colon cancer

Ramadan, Ragaa A; Morsy, Heba; Samir, Mohamed; Shamseya, Mohamed; Shalaby, Maha; El?Attar, Eman A.
Indian J Cancer ; 2022 Sep; 59(3): 394-401
Artículo | IMSEAR | ID: sea-221706

Documentos relacionados

  1. Significance of cancer testis-associated antigens (<i>SPAG9</i> and <i>FBXO39</i>) in colon cancer.
  2. Cancer testis antigen burden (CTAB): a novel biomarker of tumor-associated antigens in lung cancer.
  3. Aberrant Expression of Cancer-Testis Antigen FBXO39 in Breast Cancer and its Clinical Significance.
  4. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
  5. Systematic analysis identifies XRCC4 as a potential immunological and prognostic biomarker associated with pan-cancer.
  6. Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarker.
  7. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
  8. Pan-cancer analysis: SPAG5 is an immunological and prognostic biomarker for multiple cancers.
  9. MARCO is a potential prognostic and immunotherapy biomarker.
  10. Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy.